Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Hepatitis

Free Subscription Articles published in Vaccine Retrieve available abstracts of 90 articles: HTML format Text format

Single Articles

April 2012
1. ZHANG ZL , Zhu XJ, Wang X, Liang M, et al
   Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children.
   Vaccine. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. SU FH , Bai CH, Chu FY, Lin YS, et al
   Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
   Vaccine. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
3. BYRD KK , Lu PJ, Murphy TV
   Baseline hepatitis B vaccination coverage among persons with diabetes before implementing a U.S. recommendation for vaccination.
   Vaccine. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. WEERAKOON AP , Chen MY, Read TR, Bradshaw C, et al
   Immunity to hepatitis A when outbreaks of infection in men who have sex with men (MSM) are rare.
   Vaccine. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. MENA G , Llupia A, Garcia-Basteiro AL, Diez C, et al
   Evaluating the immunological response to hepatitis B vaccination in HIV-infected patients in clinical practice.
   Vaccine. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. OZDEMIR R , Canpolat FE, Yurttutan S, Oncel MY, et al
   Effect of needle length for response to hepatitis B vaccine in macrosomic neonates: A prospective randomized study.
   Vaccine. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. LIU H , Ma Y, Wang H, Liu Q, et al
   Quantitative evaluation of the effect of the hepatitis B vaccine based on the HBsAg- and anti-HBs-positive rates in the Chinese population over the last 33 years.
   Vaccine. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. WILLIAMS RE , Sena AC, Moorman AC, Moore ZS, et al
   Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak.
   Vaccine. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. HAYDEN CA , Streatfield SJ, Lamphear BJ, Fake GM, et al
   Bioencapsulation of the hepatitis B surface antigen and its use as an effective oral immunogen.
   Vaccine. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. KLADE CS , Schuller E, Boehm T, von Gabain A, et al
    Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccination.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2012
11. SABLAN BP , Kim DJ, Barzaga NG, Chow WC, et al
    Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. HALPERIN SA , Ward B, Cooper C, Predy G, et al
    Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
13. WANG F , Zhao YL, Ma JC, Bi SL, et al
    Long-term efficacy of 10-12 years after being immunized with Chinese hamster ovary cell derived hepatitis B vaccine in Chinese Rural Communities.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. WANG YS , Ouyang W, Liu XJ, He KW, et al
    Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. FABRIZI F , Dixit V, Messa P, Martin P, et al
    Hepatitis B virus vaccine in chronic kidney disease: Improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. OTT JJ , Stevens GA, Groeger J, Wiersma ST, et al
    Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. BECK CR , Cloke R, O'Moore E, Puleston R, et al
    Hepatitis B vaccination coverage and uptake in prisons across England and Wales 2003-2010: A retrospective ecological study.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. CHAVES SS , Fischer G, Groeger J, Patel PR, et al
    Persistence of long-term immunity to hepatitis B among adolescents immunized at birth.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. MINERVINI G , McCarson BJ, Reisinger KS, Martin JC, et al
    Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
20. HAHNE S , van den Hoek A, Baayen D, van der Sande M, et al
    Prevention of perinatal hepatitis B virus transmission in the Netherlands, 2003-2007: Children of Chinese mothers are at increased risk of breakthrough infection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. VAN RIJSWOUD E
    Reply to "Preparing for the next public debate: Universal vaccination against hepatitis B"Vaccine 29 (8 November 2011), pp. 8960-8964.
    Vaccine. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
22. ZITT E , Sprenger-Mahr H, Knoll F, Neyer U, et al
    Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
23. SHARMA HJ , Patil VD, Lalwani SK, Mangalani MV, et al
    Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. TRAN TQ , Grimes CZ, Lai D, Troisi CL, et al
    Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. ZHAO Z , Murphy TV, Jacques-Carroll L
    Progress in newborn hepatitis B vaccination by birth year cohorts-1998-2007, USA.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
26. CHAVES SS , Daniels D, Cooper BW, Malo-Schlegel S, et al
    Immunogenicity of hepatitis B vaccine among hemodialysis patients: Effect of revaccination of non-responders and duration of protection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. KACHKO A , Kochneva G, Sivolobova G, Grazhdantseva A, et al
    New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. HARDER KM , Cowan S, Eriksen MB, Krarup HB, et al
    Universal screening for hepatitis B among pregnant women led to 96% vaccination coverage among newborns of HBsAg positive mothers in Denmark.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. TOHME RA , Awosika-Olumo D, Nielsen C, Khuwaja S, et al
    Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. FREED DC , Towne VM, Casimiro DR, Zhao Q, et al
    Evaluating functional antibodies in rhesus monkeys immunized with hepatitis B virus surface antigen vaccine with novel adjuvant formulations.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. ABARCA K , Ibanez I, de la Fuente P, Cerda L, et al
    Immunogenicity and tolerability of a paediatric presentation of a virosomal hepatitis A vaccine in Chilean children aged 1-16 years.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
32. FITZSIMONS D , Kojouharova M, Hallauer J, Hendrickx G, et al
    Burden and prevention of viral hepatitis in Bulgaria.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. HOUWELING H , Spaendonck MC, Paulussen T, Verweij M, et al
    Preparing for the next public debate: Universal vaccination against hepatitis B.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. WINNOCK M , Bani-Sadr F, Pambrun E, Loko MA, et al
    Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. ALAVI-MOGHADDAM M , Alavian SM, Aalaei-Andabili SH, Eslami-Far A, et al
    Do the initial serum level changes of sCD26 have ability to predict successful treatment with IFN-alpha among naive chronic hepatitis B patients?
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
36. ZHENG H , Chen Y, Wang F, Gong X, et al
    Comparing live attenuated and inactivated hepatitis A vaccines: An immunogenicity study after one single dose.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. LEE AW , Vesikari T, Gilbert CL, Klopfer SO, et al
    Immunogenicity and safety of a Haemophilus influenzae B (Hib)-hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. SCHMEINK CE
    Co-administration of human papillomavirus-16/18 AS04-adjuvanted vaccine with hepatitis B vaccine: Randomized study in healthy girls.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. ZHU CL , Liu P, Chen T, Ni Z, et al
    Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
40. LU PJ , Byrd KK, Murphy TV, Weinbaum C, et al
    Hepatitis B vaccination coverage among high-risk adults 18-49 years, U.S., 2009.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. KURUGOL Z , Aslan A, Turkoglu E, Koturoglu G, et al
    Changing epidemiology of hepatitis A infection in Izmir, Turkey.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. RAY P , Black S, Shinefield H, Dillon A, et al
    Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
43. ISAACS D , Kilham HA, Alexander S, Wood N, et al
    Ethical issues in preventing mother-to-child transmission of hepatitis B by immunisation.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. PASSOS AM , Treitinger A, Spada C
    Hepatitis B immunity and vaccination coverage among young adult males in the Air Force in South Brazil.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. ZHANG W , Han L, Lin C, Wang H, et al
    Surface antibody and cytokine response to recombinant Chinese hamster ovary cell (CHO) hepatitis B vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. GIMENEZ-SANCHEZ F , Kieninger DM, Kueper K, Martinon-Torres F, et al
    Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal con
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. YIN Y , Li H, Wu S, Dong D, et al
    Hepatitis B virus core particles displaying Mycobacterium tuberculosis antigen ESAT-6 enhance ESAT-6-specific immune responses.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. VON TEICHMAN B
    Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
49. PAULKE-KORINEK M , Fischmeister G, Grac A, Rendi-Wagner P, et al
    Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. MELO LV , Silva MA, Calcada CD, Cavalcante SR, et al
    Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: Assessment of prevalence and vaccination coverage.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. HONG Y , Peng Y, Mi M, Xiao H, et al
    Lentivector expressing HBsAg and immunoglobulin Fc fusion antigen induces potent immune responses and results in seroconversion in HBsAg transgenic mice.
    Vaccine. 2011;29:3909-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. CORTE CD , Carlucci A, Francalanci P, Alisi A, et al
    Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. SAKSAWAD R , Likitnukul S, Warachit B, Hanvivatvong O, et al
    Immunogenicity and safety of a pediatric dose virosomal hepatitis A vaccine in Thai HIV-infected children.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. HATZ C , Beck B, Steffen R, Genton B, et al
    Real-life versus package insert: A post-marketing study on adverse-event rates of the virosomal hepatitis A vaccine Epaxal((R)) in healthy travellers.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. AKAZAWA D , Morikawa K, Omi N, Takahashi H, et al
    Production and characterization of HCV particles from serum-free culture.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. BOSHRA H , Lorenzo G, Rodriguez F, Brun A, et al
    A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
57. LAO-ARAYA M , Puthanakit T, Aurpibul L, Taecharoenkul S, et al
    Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
58. LIN SY , Liu JH, Lin CC, Wang SM, et al
    Comparison of hepatitis B surface antibody decay rates after vaccination between hemodialysis and peritoneal dialysis patients.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. ZHANG Y , Ma JC, Qi SX, Wang F, et al
    Effectiveness of a Chinese hamster ovary cell derived hepatitis B vaccine in Chinese Rural Communities.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. STRATEN PT , Andersen MH
    Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
61. BURNETT RJ , Francois G, Mphahlele MJ, Mureithi JG, et al
    Hepatitis B vaccination coverage in healthcare workers in Gauteng Province, South Africa.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. WANG H , Su X, Zhang P, Liang J, et al
    Recombinant heat shock protein 65 carrying PADRE and HBV epitopes activates dendritic cells and elicits HBV-specific CTL responses.
    Vaccine. 2011;29:2328-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. CAO J , Chen Z, Ren Y, Luo Y, et al
    Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. CEKMEZ F , Canpolat FE, Erdinc K, Cetinkaya M, et al
    Response to hepatitis B vaccine differs by birthweight among neonates.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. MOORMAN JP , Zhang CL, Ni L, Ma CJ, et al
    Impaired hepatitis B vaccine responses during chronic hepatitis C infection: Involvement of the PD-1 pathway in regulating CD4(+) T cell responses.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
66. RUSNAK JM , Gibbs P, Boudreau E, Clizbe DP, et al
    Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. BYRD KK , Santibanez TA, Chaves SS
    Predictors of hepatitis A vaccination among young children in the United States.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. NAARDING MA , Falkowska E, Xiao H, Dragic T, et al
    Hepatitis C virus soluble E2 in combination with QuilA and CpG ODN induces neutralizing antibodies in mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. CHAKVETADZE C , Roussin C, Roux J, Mallet V, et al
    Efficacy of hepatitis B sero-vaccination in newborns of African HBsAg positive mothers.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. BUNUPURADAH T , Ananworanich J, Pancharoen C, Petoumenos K, et al
    Randomized study of intradermal compared to intramuscular hepatitis B vaccination in HIV-infected children without severe immunosuppression.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. TSOU TP , Liu CC, Huang JJ, Tsai KJ, et al
    Change in hepatitis A epidemiology after vaccinating high risk children in Taiwan, 1995-2008.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. MOGHADDAM MH , Shadkam MN, Hadinedoushan H
    Immunity to hepatitis B vaccine among health care workers.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. ELEFTHERIADIS T , Liakopoulos V, Antoniadi G, Stefanidis I, et al
    Indoleamine 2,3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
74. WU Q , Zhuang GH, Wang XL, Wang LR, et al
    Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: Results of a randomized placebo-controlled trial cohort from China where endemicity is high.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
75. TIELEMANS CL , Vlasak J, Kosa D, Billiouw JM, et al
    Immunogenicity and safety of an investigational as02(v)-adjuvanted hepatitis b vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: Results of two open, randomized, comparative tria
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. SHIM J , Kim KY, Kim BH, Chun H, et al
    Anti-hepatitis B core antibody is not required for prevaccination screening in healthcare workers.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. DIAZ-MITOMA F , Halperin SA, Tapiero B, Hoffenbach A, et al
    Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of age.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
78. ZINGONE F , Morisco F, Zanetti A, Romano L, et al
    Long-term antibody persistence and immune memory to hepatitis B virus in adult celiac patients vaccinated as adolescents.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. SOBEL HL , Mantaring JB 3rd, Cuevas F, Ducusin JV, et al
    Implementing a national policy for hepatitis B birth dose vaccination in Philippines: Lessons for improved delivery.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. CHEN J , Liang Z, Lu F, Fang X, et al
    Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. SIDDIQUI MR , Gay N, Edmunds WJ, Ramsay M, et al
    Economic evaluation of infant and adolescent hepatitis B vaccination in the UK.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
82. MATHESON K , Halperin B, McNeil S, Langley JM, et al
    Hepatitis A and travel amongst Nova Scotia post-secondary students: Evidence for a targeted vs. universal immunization strategy.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. WANG XY , Zhang XX, Yao X, Jiang JH, et al
    Serum HBeAg sero-conversion correlated with decrease of HBsAg and HBV DNA in chronic hepatitis B patients treated with a therapeutic vaccine.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. STAAT MA , Stadler LP, Donauer S, Trehan I, et al
    Serologic testing to verify the immune status of internationally adopted children against vaccine preventable diseases.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. HOUWELING H , Wittevrongel CF, Verweij M, Ruitenberg EJ, et al
    Public vaccination programmes against hepatitis B in The Netherlands: Assessing whether a targeted or a universal approach is appropriate.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
86. FISCHINGER JM , Stephan B, Wasserscheid K, Eichler H, et al
    A cost-benefit analysis of blood donor vaccination as an alternative to additional DNA testing for reducing transfusion transmission of hepatitis B virus.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. BOGGILD AK , Castelli F, Gautret P, Torresi J, et al
    Vaccine preventable diseases in returned international travelers: Results from the GeoSentinel Surveillance Network.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. GUAN ZJ , Guo B, Huo YL, Guan ZP, et al
    Overview of expression of hepatitis B surface antigen in transgenic plants.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
89. XU L , Wei Y, Chen T, Lu J, et al
    Occult HBV infection in anti-HBs-positive young adults after neonatal HB vaccination.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
90. CHO HY , Kim CH, Go UY, Lee HJ, et al
    Immunization decision-making in the Republic of Korea: the structure and functioning of the Korea Advisory Committee on Immunization Practices.
    Vaccine. 2010;28 Suppl 1:A91-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: